# A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male Volunteers

> **NCT06567392** · PHASE1 · COMPLETED · sponsor: **Chengdu Suncadia Medicine Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Complement Mediated Primary or Secondary Glomerular Diseases

## Interventions

- **DRUG:** [14C] HRS-5965

## Key facts

- **NCT ID:** NCT06567392
- **Lead sponsor:** Chengdu Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-03
- **Primary completion:** 2024-10-08
- **Final completion:** 2024-10-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06567392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06567392, "A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06567392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*